FIM
USNA icon

Freedom Investment Management’s Usana Health Sciences USNA Stock Holding History

Freedom Investment Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,270
Closed -$210K – 1152
2017
Q2 		$210K Buy
+3,270
New +$201K 0.01% 965

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Freedom Investment Management's USNA Position: Q3 2017 in Review

Freedom Investment Management sold out of Usana Health Sciences (USNA) in Q3 2017, closing a stake of 3,270 shares — an estimated $210K sold.

Freedom Investment Management first reported a position in USNA in Q2 2017 and held it in 1 quarter. The position peaked at $210K in Q2 2017. 144 funds tracked by Wall St. Rank hold USNA as of Q3 2017.

  • Freedom Investment Management reported no remaining Usana Health Sciences position as of Q3 2017 after selling out during the quarter.
  • Freedom Investment Management sold 3,270 Usana Health Sciences shares in Q3 2017, an estimated $210K.
  • Freedom Investment Management first reported a position in Usana Health Sciences in Q2 2017 and held it in 1 quarter.
  • Freedom Investment Management's Usana Health Sciences position peaked at $210K in Q2 2017.
  • 144 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2017.

Based on Freedom Investment Management's 13F filing for Q3 2017, filed 3 Oct 2017.